This is a draft version - Page is not published

Financing, Equity Capital Markets

VectivBio

10/22
|
$125.3 Million
Piper Sandler served as bookrunner for VectivBio on a registered direct offering
Sub-Type
Registered Direct
Sub-Sector
Biopharma